Evidence map›Paper›PMID 31588002›Full record

ArticleCurrent biology : CB2019

Neuronal O-GlcNAcylation Improves Cognitive Function in the Aged Mouse Brain.

Elizabeth G Wheatley, Eddy Albarran, Charles W White, Gregor Bieri, Cesar Sanchez-Diaz, Karishma Pratt, Cedric E Snethlage, Jun B Ding, Saul A Villeda

Open access · hybridAbstract read
In one paragraph

Article in Current biology : CB, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 1 synthesis or guideline pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Elizabeth G WheatleyDepartment of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA; Developmental and Stem Cell Biology Graduate Program, University of California, San Francisco, San Francisco, CA 94143, USA.
Eddy AlbarranNeuroscience IDP Program, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Neurosurgery, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
Charles W WhiteDepartment of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA; Developmental and Stem Cell Biology Graduate Program, University of California, San Francisco, San Francisco, CA 94143, USA.
Gregor BieriDepartment of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA.
Cesar Sanchez-DiazDepartment of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA.
Karishma PrattDepartment of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA; Developmental and Stem Cell Biology Graduate Program, University of California, San Francisco, San Francisco, CA 94143, USA.
Cedric E SnethlageDepartment of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA.
Jun B DingNeuroscience IDP Program, Stanford University School of Medicine, Stanford, CA 94305, USA; Department of Neurosurgery, Stanford University School of Medicine, Palo Alto, CA 94304, USA.
Saul A VilledaDepartment of Anatomy, University of California, San Francisco, San Francisco, CA 94143, USA; Developmental and Stem Cell Biology Graduate Program, University of California, San Francisco, San Francisco, CA 94143, USA; Department of Physical Therapy and Rehabilitation Science, University of California, San Francisco, San Francisco, CA 94143, USA; The Eli and Edythe Broad Center for Regeneration Medicine and Stem Cell Research, San Francisco, CA 94143, USA. Electronic address: saul.villeda@ucsf.edu.
University of California, San Francisco · USStanford University · USAmerican Physical Therapy Association · US

Funding

PREDOCTORAL TRAINING IN DEVELOPMENTAL BIOLOGYT32HD007470 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Todd Nystul · 1994 to 2026
$7.7M
Dopamine modulation of synaptic plasticity and integration in the striatumR01NS091144 · NINDS · STANFORD UNIVERSITY · PI Jun Ding · 2015 to 2026
$4.2M
Role of O-GlcNAcylation in Regulating Neurodegeneration in Aging and Alzheimer’s DiseaseRF1AG062357 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VILLEDA, SAUL A · 2018 to 2018
$2.0M
Mechanisms of brain rejuvenationR01AG053382 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VILLEDA, SAUL A · 2016 to 2020
$2.0M
Dopamine Degradation Pathway and Alpha-synuclein AggregationR01NS103037 · NINDS · STANFORD UNIVERSITY · PI DING, JUN · 2017 to 2021
$1.9M
Alcohol disrupts the balance between dopamine and GABA co-released by midbrain dopamine neuronsR01AA025721 · NIAAA · STANFORD UNIVERSITY · PI DING, JUN · 2017 to 2021
$1.8M
The Role of OGT in Regulating Hippocampal Neuronal Integrity and Cognition with AgeF31AG050415 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WHEATLEY, ELIZABETH GRACE · 2015 to 2017
$115k
NIAAA NIH HHS R01 AA025721NIA NIH HHS F31 AG050415NIA NIH HHS R01 AG053382NIA NIH HHS RF1 AG062357NICHD NIH HHS T32 HD007470NINDS NIH HHS R01 NS091144NINDS NIH HHS R01 NS103037
6 · The paper itself

Abstract

Mounting evidence in animal models indicates potential for rejuvenation of cellular and cognitive functions in the aging brain. However, the ability to utilize this potential is predicated on identifying molecular targets that reverse the effects of aging in vulnerable regions of the brain, such as the hippocampus. The dynamic post-translational modification O-linked N-Acetylglucosamine (O-GlcNAc) has emerged as an attractive target for regulating aging-specific synaptic alterations as well as neurodegeneration. While speculation exists about the role of O-GlcNAc in neurodegenerative conditions, such as Alzheimer's disease, its role in physiological brain aging remains largely unexplored. Here, we report that countering age-related decreased O-GlcNAc transferase (OGT) expression and O-GlcNAcylation ameliorates cognitive impairments in aged mice. Mimicking an aged condition in young adults by abrogating OGT, using a temporally controlled neuron-specific conditional knockout mouse model, recapitulated cellular and cognitive features of brain aging. Conversely, overexpressing OGT in mature hippocampal neurons using a viral-mediated approach enhanced associative fear memory in young adult mice. Excitingly, in aged mice overexpressing neuronal OGT in the aged hippocampus rescued in part age-related impairments in spatial learning and memory as well as associative fear memory. Our data identify O-GlcNAcylaton as a key molecular mediator promoting cognitive rejuvenation.

Indexed as

AcetylglucosamineAcylationAgingAnimalsCognitionMaleMiceMice, KnockoutN-AcetylglucosaminyltransferasesAcetylglucosamineN-AcetylglucosaminyltransferasesO-GlcNAc transferaseagingbraincognitionhippocampusO-GlcNAcylationOGTrejuvenationsynaptic plasticity

Identifiers

PMID31588002
PMCPMC7199460
OpenAlexW2977249793

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.